Ikarian Capital, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $2.75 Million - $4.26 Million	-192,609 Reduced 52.47%	174,510 $2.7 Million
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $1.86 Million - $2.38 Million	-125,156 Reduced 25.42%	367,119 $6.02 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $6.09 Million - $9.96 Million	492,275 New	492,275 $9.11 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.